TACSTD2 and neoplasm: Upregulation of Trop-2 has been associated to poor prognosis of lung (8), breast (9), pancreas (10, 11), stomach (12), head and neck (13), ovary (14) and colon-rectum cancers (11), suggesting a pivotal role of this molecule in tumor progression (15) and metastatic diffusion (16).